Kura Oncology (KURA) Retained Earnings (2010 - 2026)
Kura Oncology (KURA) reported Retained Earnings of -$1.2 billion for Q1 2026, down 128171.97% year-over-year from N/an in Q1 2025, and down 6.25% quarter-over-quarter from -$1.2 billion in Q4 2025.
Kura Oncology (KURA) Retained Earnings (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 17 years of Retained Earnings data on file, last reported at -$1.2 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.2 billion, down 128171.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 128171.97% YoY), and the FY2025 annual result was -$1.2 billion, down 31.12% from the prior year.
- Retained Earnings fell to -$1.2 billion in Q1 2026 per KURA's latest filing, from -$1.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $974000.0 in Q1 2025 and troughed at -$1.2 billion in Q1 2026.
- A 5-year average of -$454.1 million and a median of -$9.4 million in 2022 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 100.13% in 2025 and fell as far as 219980.56% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$8.0 million in 2022, then jumped by 84.18% to -$1.3 million in 2023, then slumped by 70350.2% to -$895.4 million in 2024, then tumbled by 31.12% to -$1.2 billion in 2025, then slipped by 6.25% to -$1.2 billion in 2026.
- Business Quant data shows KURA's Retained Earnings at -$1.2 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | -1.25 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.25 Bn |
| Dec 31, 2025 | -1.17 Bn |
| Sep 30, 2025 | -1.09 Bn |
| Jun 30, 2025 | -1.02 Bn |
| Mar 31, 2025 | 974,000.00 |
| Dec 31, 2024 | -895.42 Mn |
| Sep 30, 2024 | -876.21 Mn |
| Jun 30, 2024 | -463,000.00 |
| Mar 31, 2024 | -770.96 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -3.54 Mn |
| Jun 30, 2023 | -5.22 Mn |
| Mar 31, 2023 | -602.88 Mn |
| Dec 31, 2022 | -8.03 Mn |
| Sep 30, 2022 | -9.42 Mn |
| Jun 30, 2022 | -7.82 Mn |
| Mar 31, 2022 | -6.65 Mn |
| Dec 31, 2021 | -1.79 Mn |
| Sep 30, 2021 | -400.23 Mn |
| Jun 30, 2021 | -393,000.00 |